Valuation : SMS Pharmaceuticals Limited

Market Cap 35.11B 369M 318M 298M 272M 512M 515M 3.53B 1.38B 17.8B 1.39B 1.36B 58.94B P/E 2024
30.3x
P/E 2025 27.3x
Enterprise Value 37.8B 397M 342M 321M 293M 551M 555M 3.81B 1.48B 19.17B 1.49B 1.46B 63.46B EV / Sales 2024
2.47x
EV / Sales 2025 2.75x
Free-Float
23.43%
Yield 2024
0.22%
Yield 2025 0.19%
1 day-1.21%
1 week+3.69%
Current month-1.90%
1 month-1.90%
3 months+2.01%
6 months-1.94%
Current year+18.36%
1 week 349.95
Extreme 349.95
378.1
1 month 349.95
Extreme 349.95
385.5
Current year 293.55
Extreme 293.55
446.5
1 year 230.75
Extreme 230.75
446.5
3 years 111.95
Extreme 111.95
446.5
5 years 54.5
Extreme 54.5
446.5
10 years 23.55
Extreme 23.55
446.5
Manager TitleAgeSince
Chief Executive Officer 66 30/08/1990
Director of Finance/CFO - 13/09/2017
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 66 30/08/1990
Director/Board Member 38 05/06/2020
Director/Board Member 48 29/05/2018
Change 5-day change 1-year change 3-year change Capi.($)
-1.21%+3.69% - - 366M
-2.81%+0.99%+23.39%+73.53% 50.05B
+1.14%+1.47%+56.16%+123.40% 40.29B
+0.56%+5.80%+17.83%+86.59% 12.17B
+0.98%-1.04%-10.35%+13.15% 11.96B
+0.19%-.--%+29.35%+150.00% 9.25B
-0.38%-1.88%+24.93%+48.22% 7.62B
-0.39%+3.33%+28.21%+222.15% 7.36B
+1.43%+1.70%+45.95%-9.99% 7.21B
-0.84%-2.36%-36.62%+16.04% 5.26B
Average -0.13%+1.10%+19.87%+80.34% 16.8B
Weighted average by Cap. -0.49%+1.77%+28.67%+87.75%

Financials

2024 2025
Net sales 7.09B 74.54M 64.18M 60.26M 55.01M 103M 104M 714M 278M 3.6B 280M 274M 11.91B 7.83B 82.27M 70.83M 66.51M 60.71M 114M 115M 788M 307M 3.97B 309M 302M 13.14B
Net income 498M 5.24M 4.51M 4.23M 3.86M 7.26M 7.31M 50.17M 19.52M 253M 19.66M 19.23M 837M 691M 7.27M 6.26M 5.87M 5.36M 10.07M 10.15M 69.61M 27.08M 351M 27.28M 26.69M 1.16B
Net Debt 2.45B 25.71M 22.14M 20.79M 18.98M 35.65M 35.9M 246M 95.84M 1.24B 96.54M 94.45M 4.11B 2.69B 28.3M 24.37M 22.88M 20.88M 39.23M 39.51M 271M 105M 1.37B 106M 104M 4.52B
Logo SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The Company products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The Company has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Employees
1,470
Date Price Change Volume
01/09/26 367.10 -1.21% 5,578
31/08/26 ₹371.60 +4.56% 7,393
28/08/26 ₹355.40 -2.03% 3,688
27/08/26 ₹362.75 +1.37% 8,187
26/08/26 ₹357.85 +0.35% 7,434

Annual profits - Rate of surprise